Ottimo Pharma Emerges From Stealth With Backing From Medicxi And Management Team Led By David Epstein To Accelerate Development Of A Novel PD1/VEGFR2 Bi-Functional Antibody Planned To Enter The Clinic In 2025

(MENAFN - PR Newswire) DavidEpstein, formerly CEO of Seagen, joins as Chair & Chief Executive Officer Mehdi Shahidi, previously SVP and Chief Medical Officer at Boehringer ...

By: menafn